EPHX2 and obesity due to melanocortin 4 receptor deficiency: Furthermore, the rationale for combining DER specifically with the n-3FA DHA is strengthened by the finding that obesity may diminish the antitumor effect of DHA against breast cancer by increasing sEH which hydrolyzes and inactivates tumor protective DHA-derived oxylipins produced by CYP epoxygenases [24].